| 1. |
SSRIs recommended as first-line in social anxiety disorder |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 2-2
&NA;,
Preview
|
PDF (847KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 2. |
Making the ‘right choice’ for antiepileptic drug therapy |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 3-4
Helen Commander,
Preview
|
PDF (1559KB)
|
|
摘要:
In recent years, the number of available antiepileptic drugs (AEDs) has more than doubled and more agents are awaiting regulatory approval or are in late clinical development. This has considerably increased treatment options for physicians and patients.*But how easy is it to select the ‘right drug’ for each patient, and have the newer drugs made that decision any easier? The relative roles of new AEDs in the treatment of epilepsy were discussed during workshop and satellite sessions at the third Congress of the European Federation of Neurological Societies [Seville, Spain; September 1998]. These sessions provided opportunities for experienced clinicians to discuss which drugs they use in a practical setting.
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 3. |
The jury's still out on randomised trials |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 4-4
&NA;,
Preview
|
PDF (787KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 5-5
&NA;,
Preview
|
PDF (818KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 5. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 6-6
&NA;,
Preview
|
PDF (738KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 6. |
Cost effectiveness of statinsare the differences really important? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 7-8
Mark Greener,
Preview
|
PDF (1591KB)
|
|
摘要:
With the clinical effectiveness of HMG CoA reductase inhibitors (statins) now well established, pharmaceutical companies' thoughts increasingly turn to highlighting differences within the class - clinical, pharmacological and economic. Several studies presented at meetings over the last few months suggest that some newer statins are more cost effective than older members of the class. Nevertheless, a recent paper emphasises that, for primary prevention at least, the issues preventing wider statin prescribing may be more fundamental than relatively minor differences in cost effectiveness.
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 7. |
Dyspepsia management improves with guideline use |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 8-8
&NA;,
Preview
|
PDF (751KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 8. |
Bradykinin contributes to the effects of ACE inhibitors |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 9-9
&NA;,
Preview
|
PDF (751KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 9. |
CTLs can protect against retroviral infection |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 10-10
&NA;,
Preview
|
PDF (730KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 10. |
Plant toxins as tools for understanding CNS disorders |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1162,
1998,
Page 11-12
Jo Barnes,
Preview
|
PDF (1529KB)
|
|
摘要:
Plants are sources of novel therapeutics, but can also provide clues to the causes of neurodegenerative disease. Plant toxins are being used as tools in attempts to understand what causes the pathology seen in central nervous system (CNS) disorders, such as Alzheimer's disease, Parkinson's disease and motor neurone disease, delegates were told at a symposium entitled ‘Plants and the central nervous system’, which was held during the 135th British Pharmaceutical Conference [Eastbourne, UK; September 1998]. Other researchers are going back to the future by looking at ancient herbal medicines for clues in their search for CNS therapeutics.
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
首页
